期刊文献+

注射用兰索拉唑制备、质量控制及稳定性考察 被引量:4

Preparation,quality control and stability study for lansoprazole for injection
原文传递
导出
摘要 目的:制备注射用兰索拉唑,建立其质量控制方法并考察其稳定性。方法:制备注射用兰索拉唑;采用高效液相色谱法测定其含量及有关物质,并对制剂进行稳定性考察。结果:本品处方以每瓶50mg甘露醇作为赋形剂,用0.1mol·L-1氢氧化钠溶液调节pH为11.0;兰索拉唑浓度在20.51~205.1μg·mL-1范围内线性关系良好(r=0.9999,n=5);恒温加速试验6个月及长期留样24个月时主药含量及有关物质未见明显变化。结论:该制剂处方工艺可行,质量可控,稳定性良好;所建立的含量测定方法重复性好,专属性强,结果准确可靠。 Objective: To prepare lansoprazole for injection, establish its quality control and determine its stability. Methods:The type and dosage of the excipients in the formula were optimized the lansoprazole for injec- tion, with its content determined by HPLC. Meanwhile its stability was tested. Results:50 mg per bottle mannitol so- lution was selected with 0. 1 tool ~ L-t sodium hydroxide solution as the major exeipient adjusting pH to 11.0;The linear range of lansoprazole was 20.51 - 205.1 μg· mL- 1, r = 0. 9999 ( n = 5 ) ; No obvious changes were observed at 6 months of an accelerated test or 24 months of long - term storage test. Conclusion : The preparation is controlla- ble and stable in quality, and the established method is reliable and specific for the quantitation of lansoprazole.
出处 《药物分析杂志》 CAS CSCD 北大核心 2009年第9期1510-1513,共4页 Chinese Journal of Pharmaceutical Analysis
关键词 注射用兰索拉唑 制备 质量控制 稳定性 lansoprazole for injection preparation quality control stability
  • 相关文献

参考文献4

  • 1Maisch NM, Smith C. Lansoprazole Ⅳ : A new delivery method for an established PPI. Formulary, 2003,38 ( 12 ) : 705.
  • 2USP 30 - NF 25. 2007 Asian Edition. Volume 2, Official Monographs, lansoprazole ( 2451 - 2452 ).
  • 3ChP(中国药典).2005.Vol Ⅱ(二部):455.
  • 4杨艳,李冰,孙英华,方金玲,何仲贵.注射用兰索拉唑与常用输液的配伍稳定性[J].中国新药杂志,2007,16(10):794-796. 被引量:20

二级参考文献3

共引文献24

同被引文献17

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部